Overview

Ibuprofen 4% (w/v) Pivotal Bioequivalence Study

Status:
Completed

Trial end date:
2016-05-06

Target enrollment:

Participant gender:

Summary

Bioequivalence evaluation of Nurofen for Children® with reference formulation of Algifor® Junior by determining and comparing the rate and extent of absorption in both fed and fasted states

Phase:

Phase 1

Details

Lead Sponsor:

Reckitt Benckiser Healthcare (UK) Limited

Treatments:

Ibuprofen